Search results
Results From The WOW.Com Content Network
Original Von Hippel's description of disease. The German ophthalmologist Eugen von Hippel first described angiomas in the eye in 1904. [30] Arvid Lindau described the angiomas of the cerebellum and spine in 1927. [31] The term Von Hippel–Lindau disease was first used in 1936; however, its use became common only in the 1970s. [9]
The von Hippel–Lindau tumor suppressor gene generally has a germline mutation. This suppressor gene is also called elongin binding protein and G7 protein. The VHL protein is involved in up-regulation of hypoxic response via the [[hypoxia inducible factor [HIF]-1 alpha]]. Mutations generally prevent the production of any functional VHL protein ...
The Von Hippel–Lindau tumor suppressor also known as pVHL is a protein that, in humans, is encoded by the VHL gene. Mutations of the VHL gene are associated with Von Hippel–Lindau disease, which is characterized by hemangioblastomas of the brain, spinal cord and retina. It is also associated with kidney and pancreatic lesions.
Locations of the main types of cysts and tumors in Von Hippel–Lindau disease. [55] Von Hippel-Lindau (VHL) disease is an autosomal dominant condition caused by mutations of the VHL gene. [56] Approximately one-in-five cases are de novo rather than familial and it has nearly complete penetrance. [57] VHL occurs in an estimated 1 in 36,000 ...
Inactivation of von Hippel–Lindau (VHL) gene by mutation and promoter hypermethylation; Gain of chromosome 5q; Loss of chromosomes 8p, 9p, and 14q; In 2009–2010, five new frequently mutated genes were discovered in CCRCC; KDM6A/UTX, SETD2, KDM5C/JARID1C, and MLL2 [30] CCRCC is derived from the proximal convoluted tubule
Von Hippel–Lindau disease: It can be associated with Von Hippel–Lindau disease and is a rare genetic multi-system disorder characterized by the abnormal growth of tumours in the body. Symptoms may include headaches, problems with balance and walking, dizziness, weakness of the limbs, vision problems and high blood pressure.
Pheochromocytomas occur in patients of all ages, and may be sporadic, or associated with a hereditary cancer syndrome, such as multiple endocrine neoplasia (MEN) types IIA and IIB, neurofibromatosis type I, or von Hippel–Lindau syndrome. Only 10% of adrenal pheochromocytomas are malignant, while the rest are benign tumors.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Von_Hippel-Lindau_syndrome&oldid=324569466"https://en.wikipedia.org/w/index.php?title=Von_Hippel-Lindau